0001127602-19-018474.txt : 20190514 0001127602-19-018474.hdr.sgml : 20190514 20190514161354 ACCESSION NUMBER: 0001127602-19-018474 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190513 FILED AS OF DATE: 20190514 DATE AS OF CHANGE: 20190514 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Farrell Michael J. CENTRAL INDEX KEY: 0001485164 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15317 FILM NUMBER: 19822862 MAIL ADDRESS: STREET 1: C/O REMED INC STREET 2: 9001 SPECTRUM CTR. BLVD. CITY: SAN DIEGO, STATE: CA ZIP: 92123 FORMER NAME: FORMER CONFORMED NAME: Farrell Michael DATE OF NAME CHANGE: 20100224 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RESMED INC CENTRAL INDEX KEY: 0000943819 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 980152841 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 9001 SPECTRUM CENTER BLVD. CITY: SAN DIEGO STATE: CA ZIP: 92123 BUSINESS PHONE: 8587462400 MAIL ADDRESS: STREET 1: 9001 SPECTRUM CENTER BLVD. CITY: SAN DIEGO STATE: CA ZIP: 92123 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2019-05-13 0000943819 RESMED INC RMD 0001485164 Farrell Michael J. RESMED INC. 9001 SPECTRUM CENTER BLVD SAN DIEGO CA 92123 1 Chief Executive Officer ResMed Common Stock 2019-05-13 4 M 0 6651 43.63 A 292988 D ResMed Common Stock 2019-05-13 4 S 0 6391 109.699 D 286597 D ResMed Common Stock 2019-05-13 4 S 0 260 110.247 D 286337 D ResMed Common Stock 10340 I Lisette and Michael Farrell Family Trust ResMed Common Stock Options 43.63 2019-05-13 4 M 0 6651 0 D 2014-03-01 2020-03-01 ResMed Commmon Stock 6651 59855 D The transaction was conducted under a Rule 10b5-1 plan. Includes 54.834 shares of ResMed stock purchased on April 30, 2019, through the ResMed Employee Stock Purchase Plan. This transaction was executed in multiple trades at prices ranging from $109.17 to $110.16. The price reported above reflects the weighted average sale price. This transaction was executed in multiple trades at prices ranging from $109.17 to $110.29. The price reported above reflects the weighted average sale price. Represents date options first became exercisable. Options vest 1/3 per year. Michael J. Farrell, Chief Executive Officer 2019-05-14